Clinical Signs definition

Clinical Signs means changes in a Pet’s normal healthy state, bodily function or behavior observed by you, a Veterinarian, or other observer.
Sample 1Sample 2
Clinical Signs means the objective evidence of disease.
Sample 1Sample 2Sample 3
Clinical Signs means any changes to the Insured Pet’s normal healthy state.
Sample 1Sample 2

Examples of Clinical Signs in a sentence

  • If Your Pet has NOT shown Clinical Symptoms or Clinical Signs of a Chronic and/ or Recurrent Condition(s) for a period of 24 months prior to the Policy Coverage Effective Date, We may consider this Condition NOT pre-existing by definition and allow the Medical Condition to be eligible for Benefits.

  • Any costs relating to an Illness which began or started showing Clinical Signs within the first 14 days or an Injury within the first 48 hours of the start date of Your Policy (this exclusion is not applicable to renewed policies).

  • No matter where the Injury, Illness or Clinical Sign(s) occur or happen in, or on, any part of Your Pet’s body.

  • For the cost of dental Treatment unless Your Pet had a dental examination carried out by a Vet in the twelve (12) months before the Clinical Signs of the Injury or Illness giving rise to the claim were first noted.

  • Is injured or shows the first Clinical Signs of any Illness while You are away or up to 7 days before You are due to leave and needs immediate life saving surgery.

  • Costs resulting from any Illness first occurring or showing Clinical Signs within the first 14 days of the start of cover for Your Pet (this exclusion is not applicable to renewed policies).

  • Guidance Document on the Recognition, Assessment and Use of Clinical Signs as Humane Endpoints for Experimental Animals Used in Safety Evaluation.

  • The cost of nasal fold, skin fold, stenotic nares and soft palate resections, enlarged tongue (macroglossa), everted laryngeal saccules, Gastrointestinal Tract and Brachycephalic Airway Obstruction (BOAS), that occur in the first twelve (12) months of cover including free cover policy, regardless of Your Pet showing Clinical Signs of the Condition or not, prior to commencement of cover or within the twenty-one (21) day Waiting Period.

  • You must get a Vet to examine and treat Your Pet as soon as possible after it shows Clinical Signs of an Injury or an Illness.

  • Guidance Document on the Recognition, Assessment and Use of Clinical Signs as Humane Endpoints.


More Definitions of Clinical Signs

Clinical Signs means changes in a Pet’s normal:
Sample 1
Clinical Signs means a visible or detectable change in the pet’s normal healthy state, condition, appearance or bodily function.
Sample 1
Clinical Signs means: Changes in Your Pet’s normal healthy state, bodily functions, or behavior as observed by any individual and recorded in Your Pet’s medical records unless caused by an Accident or Illness.
Sample 1
Clinical Signs means changes in the normal healthy state, bodily function, or behavior of Your Pet observed by You, a Veterinarian, or other observer.
Sample 1
Clinical Signs means a change/s in your Pet’s normal healthy state, its bodily functions and/ or its behaviour.
Sample 1
Clinical Signs means any changes to your Pet’s normal healthy state, behaviour or bodily functions.
Sample 1

Related to Clinical Signs

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Biological safety cabinet means a containment unit suitable for the preparation of low to moderate risk agents where there is a need for protection of the product, personnel, and environment, according to National Sanitation Foundation (NSF) Standard 49.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Diagnostic clinical procedures manual means a collection of written procedures that describes each method (and other instructions and precautions) by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration.

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Clinical Data means the information concerning the safety or performance that is generated from the use of a device and that are sourced from the following:

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products

  • Marijuana products means concentrated marijuana products and marijuana products that are comprised of marijuana and other ingredients and are intended for use or consumption, such as, but not limited to, edible products, ointments, and tinctures.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Clinical Staff means those employees of a provider who are responsible for providing clinical services to clients.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.